Release Date: 04/05/23 14:34 Summary: Units on Issue Disclosure - April 2023 Price Sensitive: No Download Document 213.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%